Skip to main content
Top
Published in: Cancer Causes & Control 2/2016

01-02-2016 | Original paper

Effect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patients

Authors: Thine Hvid, Birgitte Lindegaard, Kamilla Winding, Peter Iversen, Klaus Brasso, Thomas P. J. Solomon, Bente K. Pedersen, Pernille Hojman

Published in: Cancer Causes & Control | Issue 2/2016

Login to get access

Abstract

Aim

Physical activity after prostate cancer diagnosis has been shown to reduce the risk of disease progression. Here, we aimed to evaluate the effect of a 2-year home-based endurance training intervention on body composition, biomarkers levels, and prostate-specific antigen (PSA) doubling time as a surrogate end-point for progressing disease.

Methods

Out-clinic patients with either biochemical recurrence following radical prostatectomy or patients managed on active surveillance were randomized to either 24 months (3 times/week) of home-based endurance training or usual care. Aerobic fitness, body composition, insulin sensitivity, and biomarkers were measured at 0, 6, and 24 months of intervention. PSA doubling time (PSADT) was calculated based on monthly PSA measurements.

Results

Twenty-five patients were enrolled, and 19 patients completed the study. PSADT increased in the training group from 28 to 76 months (p < 0.05) during the first 6 months and was correlated with changes in VO2max (p < 0.01, r 2 = 0.41). The training group lost 3.6 ± 1.0 kg (p < 0.05) exclusively as fat mass, yet the changes in body composition were not associated with the increased PSADT. The training group showed significant improvements in plasma triglycerides, adiponectin, IGF-1, IGFBP-1, and fasting glucose levels, but no changes in insulin sensitivity (measured as Matsuda index), testosterone, cholesterols, fasting insulin, plasma TNF-alpha, IL-6, or leptin levels. The control group showed no changes in any of the evaluated parameters across the 2-year intervention.

Conclusion

In this small randomized controlled trial, we found that improvements in fitness levels correlated with increasing PSADT, suggesting a link between training and disease progression.
Literature
1.
go back to reference Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM (2011) Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 71(11):3889–3895PubMedPubMedCentralCrossRef Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM (2011) Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 71(11):3889–3895PubMedPubMedCentralCrossRef
2.
go back to reference Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM (2011) Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 29(6):726–732PubMedPubMedCentralCrossRef Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM (2011) Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 29(6):726–732PubMedPubMedCentralCrossRef
3.
go back to reference Payton S (2013) Prostate cancer: optimizing exercise interventions for men on ADT. Nat Rev Urol 10(11):615PubMedCrossRef Payton S (2013) Prostate cancer: optimizing exercise interventions for men on ADT. Nat Rev Urol 10(11):615PubMedCrossRef
4.
go back to reference Culos-Reed SN, Robinson JW, Lau H et al (2010) Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Support Care Cancer 18(5):591–599PubMedCrossRef Culos-Reed SN, Robinson JW, Lau H et al (2010) Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Support Care Cancer 18(5):591–599PubMedCrossRef
5.
go back to reference Segal RJ, Reid RD, Courneya KS et al (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21(9):1653–1659PubMedCrossRef Segal RJ, Reid RD, Courneya KS et al (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21(9):1653–1659PubMedCrossRef
6.
go back to reference Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU (2010) Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 28(2):340–347PubMedCrossRef Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU (2010) Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 28(2):340–347PubMedCrossRef
7.
go back to reference Hvid T, Winding K, Rinnov A et al (2013) Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy. Endocr Relat Cancer 20(5):621–632PubMedCrossRef Hvid T, Winding K, Rinnov A et al (2013) Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy. Endocr Relat Cancer 20(5):621–632PubMedCrossRef
8.
go back to reference Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470PubMedCrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470PubMedCrossRef
9.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419PubMedCrossRef
10.
go back to reference Ornish D, Weidner G, Fair WR et al (2005) Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174(3):1065–1069PubMedCrossRef Ornish D, Weidner G, Fair WR et al (2005) Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174(3):1065–1069PubMedCrossRef
11.
go back to reference Frattaroli J, Weidner G, Dnistrian AM et al (2008) Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology 72(6):1319–1323PubMedCrossRef Frattaroli J, Weidner G, Dnistrian AM et al (2008) Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology 72(6):1319–1323PubMedCrossRef
12.
go back to reference Hebert JR, Hurley TG, Harmon BE, Heiney S, Hebert CJ, Steck SE (2012) A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer. Cancer Epidemiol 36(2):e128–e136PubMedPubMedCentralCrossRef Hebert JR, Hurley TG, Harmon BE, Heiney S, Hebert CJ, Steck SE (2012) A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer. Cancer Epidemiol 36(2):e128–e136PubMedPubMedCentralCrossRef
13.
go back to reference Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H (2001) PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc 76(6):576–581PubMedCrossRef Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H (2001) PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc 76(6):576–581PubMedCrossRef
14.
go back to reference Klotz L (2006) Active surveillance with selective delayed intervention for favorable risk prostate cancer. Urol Oncol 24(1):46–50PubMedCrossRef Klotz L (2006) Active surveillance with selective delayed intervention for favorable risk prostate cancer. Urol Oncol 24(1):46–50PubMedCrossRef
15.
go back to reference Thomsen FB, Brasso K, Klotz L, Røder MA, Berg KD, Iversen P (2014) Active surveillance for clinically localized prostate cancer—a systematic review. J Surg Oncol 109(8):830–835PubMedCrossRef Thomsen FB, Brasso K, Klotz L, Røder MA, Berg KD, Iversen P (2014) Active surveillance for clinically localized prostate cancer—a systematic review. J Surg Oncol 109(8):830–835PubMedCrossRef
16.
go back to reference Thomsen FB, Christensen IJ, Brasso K, Røder MA, Iversen P (2014) Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer. BJU Int 113(5b):E98–E105PubMedCrossRef Thomsen FB, Christensen IJ, Brasso K, Røder MA, Iversen P (2014) Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer. BJU Int 113(5b):E98–E105PubMedCrossRef
17.
18.
go back to reference Baxter RC (2014) IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer 14(5):329–341PubMedCrossRef Baxter RC (2014) IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer 14(5):329–341PubMedCrossRef
19.
go back to reference Ornish D, Lin J, Chan JM et al (2013) Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 14(11):1112–1120PubMedCrossRef Ornish D, Lin J, Chan JM et al (2013) Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 14(11):1112–1120PubMedCrossRef
20.
go back to reference Park S, Kim TN, Nam J et al (2012) Recovery of overall exercise ability, quality of life, and continence after 12 week combined exercise intervention in elderly patients who underwent radical prostatectomy: a randomised controlled study. Urology 80:299–305PubMedCrossRef Park S, Kim TN, Nam J et al (2012) Recovery of overall exercise ability, quality of life, and continence after 12 week combined exercise intervention in elderly patients who underwent radical prostatectomy: a randomised controlled study. Urology 80:299–305PubMedCrossRef
21.
go back to reference Zopf EM, Bloch W, Machtens S, et al (2015) Effects of a 15-months supervised exercise program on physical and psychological outcomes in prostate cancer patients following prostatectomy: the ProReHab study. Intergr Cancer Ther 14(5):409–418CrossRef Zopf EM, Bloch W, Machtens S, et al (2015) Effects of a 15-months supervised exercise program on physical and psychological outcomes in prostate cancer patients following prostatectomy: the ProReHab study. Intergr Cancer Ther 14(5):409–418CrossRef
22.
go back to reference Gardner JR, Livingston PM, Fraser SF (2014) Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol 32(4):335–346PubMedCrossRef Gardner JR, Livingston PM, Fraser SF (2014) Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol 32(4):335–346PubMedCrossRef
24.
go back to reference Loprinzi PD, Kohli M (2013) Effect of physical activity and sedentary behavior on serum prostate-specific antigen concentrations: results from the National Health and Nutrition Examination Survey (NHANES), 2003–2006. Mayo Clin Proc 88(1):11–21PubMedCrossRef Loprinzi PD, Kohli M (2013) Effect of physical activity and sedentary behavior on serum prostate-specific antigen concentrations: results from the National Health and Nutrition Examination Survey (NHANES), 2003–2006. Mayo Clin Proc 88(1):11–21PubMedCrossRef
25.
go back to reference Burton AJ, Martin RM, Donovan JL et al (2012) Associations of lifestyle factors and anthropometric measures with repeat PSA levels during active surveillance/monitoring. Cancer Epidemiol Biomark Prev 21(10):1877–1885CrossRef Burton AJ, Martin RM, Donovan JL et al (2012) Associations of lifestyle factors and anthropometric measures with repeat PSA levels during active surveillance/monitoring. Cancer Epidemiol Biomark Prev 21(10):1877–1885CrossRef
27.
go back to reference Christensen JF, Jones LW, Andersen JL, Daugaard G, Rorth M, Hojman P (2014) Muscle dysfunction in cancer patients. Ann Oncol 25(5):947–958PubMedCrossRef Christensen JF, Jones LW, Andersen JL, Daugaard G, Rorth M, Hojman P (2014) Muscle dysfunction in cancer patients. Ann Oncol 25(5):947–958PubMedCrossRef
28.
go back to reference Cao Y, Ma J (2011) Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res 4(4):486–501CrossRef Cao Y, Ma J (2011) Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res 4(4):486–501CrossRef
29.
go back to reference Freedland SJ, Platz EA (2007) Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 29:88–97PubMedCrossRef Freedland SJ, Platz EA (2007) Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 29:88–97PubMedCrossRef
30.
go back to reference Joshu CE, Mondul AM, Menke A et al (2011) Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res 4(4):544–551CrossRef Joshu CE, Mondul AM, Menke A et al (2011) Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res 4(4):544–551CrossRef
Metadata
Title
Effect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patients
Authors
Thine Hvid
Birgitte Lindegaard
Kamilla Winding
Peter Iversen
Klaus Brasso
Thomas P. J. Solomon
Bente K. Pedersen
Pernille Hojman
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 2/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0694-1

Other articles of this Issue 2/2016

Cancer Causes & Control 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine